Clinical Trial Update: Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of trastuzumab in non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Armando Santoro, MD | Conditions: NON-SMALL CELL LUNG CANCER | Phase 2 | Status: TERMINATED